Genmab Reports 36% Revenue Growth in H1 2024by Mark Eisenberg 15.08.2024Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
B. Riley Financial Faces Plunge Amid SEC Investigationby Mark Eisenberg 15.08.2024B. Riley shares fall 46% as SEC probes financial disclosures and dividend suspension signals potential risks.
Fed Action Highlights Crypto Compliance Challengesby John Darbie 15.08.2024Customers Bank faces Fed scrutiny, revealing hurdles in crypto-banking partnerships and regulatory compliance.
iCAD’s Revenue Surges with AI and SaaS Focusby Mark Eisenberg 15.08.2024iCAD's Q2 revenue increased by 21% as the company shifts to a cloud-based SaaS model, aiming for enhanced profitability.
NET Power Makes Strides in Clean Energy Pushby Mark Eisenberg 15.08.2024NET Power progresses on clean power, aiming for $60/MWh. Project Permian on track, driving utility-scale technology.
Hyperscalers Bet Big on AI Amid Rising Cloud Spendby Lilu Anderson 15.08.2024Hyperscalers like AWS, Azure, and Google Cloud boost AI offerings as global cloud spend hits $78.2B, growing 19% YoY in ...
Glanbia Sees Strong H1 2024 Growth, EPS Up 12.4%by Mark Eisenberg 15.08.2024Glanbia reports 12.4% EPS growth in H1 2024 amid strong demand and strategic acquisitions.
AI Helps ALS Patients Communicate Uniquelyby Lilu Anderson 15.08.2024Brain implants and AI voice technology enable ALS patients to communicate effectively.
Cathie Wood’s Latest Stock Picks: Amazon, Roku, Guardantby Mark Eisenberg 15.08.2024Cathie Wood seizes volatility by investing in Amazon, Roku, and Guardant Health for potential growth amidst market fluctuations.
AI Revolutionizes Healthcare Data Analysisby Lilu Anderson 15.08.2024AI tools like those from GE and AWS aim to revolutionize healthcare by unlocking vast amounts of underutilized medical data.